APAC’s growing focus on genAI and more briefs

More APAC leaders to invest in genAI: report

Asia-Pacific will see increased investment in generative AI technology over the coming years. 

In the ninth edition of Royal Philips’ Future Health Index report, over six in 10 APAC leaders polled said they plan to invest in genAI in the next three years. At present, almost 40% of them have already invested in the technology. 

While there is great enthusiasm about healthcare AI’s potential, almost all leaders surveyed in the region said they are heavily concerned about “data bias in AI applications widening disparities in health outcomes.”

To mitigate its risk, leaders look to make AI more transparent, ensure diversity in the use of data and AI, provide continuous AI training and education, and implement policies for the ethical use of data and AI. 

Amazon’s genAI powers new medical coder in Korea

Clinical data solutions provider J&P Medi from South Korea has unveiled a new generative AI-driven medical coder on its cloud-based clinical trial data management platform.

The Maven Coder Express is built using the Amazon Bedrock genAI service on Amazon Web Services, which automates data ingestion, retrieval, prompt augmentation, and citations.

It runs on three AI models: Anthropic’s Claude 3.5 Sonnet, Claude 3 Haiku, and Amazon Titan Text Embedding v2. It also supports 13 languages, including Korean, English, German, Japanese, and Chinese. 

The genAI-powered medical coder has been certified as a MedDRA Coder by the International Medical Terminology, given its high accuracy and consistency in medical coding results.

Bayada Korea to set up digital diabetes service with Kakao Healthcare

Kakao’s digital health arm Kakao Healthcare has recently partnered with Bayada Home Health Care to improve patients’ capability to manage their health at home. 

According to a press statement, they plan to put up online and offline consultation channels leveraging Kakao Healthcare’s AI-driven digital diabetes management service, Pasta. The service uses AI to provide smart recommendations on managing an individual’s blood sugar level, which it also tracks and analyses via connection to a continuous glucose monitoring device. 

This collaboration also seeks to expand the Pasta service abroad through Bayada’s international network.